Millipore Sigma Vibrant Logo

AGX819 SARS-CoV-2 Spike Protein Recombinant Antigen

COVID-19 Spike Protein Recombinant Antigen, expressed in HEK293 cells, Cat. No. AGX819 is used as Positive Control.

View Products on Sigmaaldrich.com
AGX819
100 μg  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
—
Request Pricing
—
Fulfillment and Delivery Delayed Fulfillment and Delivery Delayed
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

       

      Contact Customer Service

      Overview

      Replacement Information
      Description
      Catalogue NumberAGX819
      DescriptionSARS-CoV-2 Spike Protein Recombinant Antigen
      Alternate Names
      • COVID-19
      • 2019-nCoV
      Background InformationCoronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 spike antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).
      References
      Product Information
      HS Code3002 15 90
      PresentationPurified protein in Tris Buffer with salts and additives without preservatives, pH 8.0.
      Quality LevelMQ100
      Applications
      ApplicationCOVID-19 Spike Protein Recombinant Antigen, expressed in HEK293 cells, Cat. No. AGX819 is used as Positive Control.
      Key Applications
      • Positive Control
      Biological Information
      HostHuman Recombinant
      SpecificitySARS-CoV-2
      Purification MethodAffinity Chromatography
      UniProt Number
      Molecular Weight138 kDa
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at -10°C to -25°C from date of receipt. Avoid repeated freeze/thaw cycles.
      Packaging Information
      Material Size100 μg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      AGX819 04061842605903

      Documentation

      SARS-CoV-2 Spike Protein Recombinant Antigen SDS

      Title

      Safety Data Sheet (SDS) 

      SARS-CoV-2 Spike Protein Recombinant Antigen Certificates of Analysis

      TitleLot Number
      SARS-CoV-2 Spike Protein - 3677719 3677719
      SARS-CoV-2 Spike Protein Recombinant Antigen - 3611072 3611072
      SARS-CoV-2 Spike Protein Recombinant Antigen - 3615444 3615444
      SARS-CoV-2 Spike Protein Recombinant Antigen - 3666024 3666024
      SARS-CoV-2 Spike Protein Recombinant Antigen - 3678862 3678862
      SARS-CoV-2 Spike Protein Recombinant Antigen - 3694761 3694761
      SARS-CoV-2 Spike Protein Recombinant Antigen - 3703595 3703595
      SARS-CoV-2 Spike Protein Recombinant Antigen - 3704755 3704755
      SARS-CoV-2 Spike Protein Recombinant Antigen - 3726525 3726525
      SARS-CoV-2 Spike Protein Recombinant Antigen - 3746854 3746854
      Show more